Slovenia
Colorectal Cancer turns everything upside down

This March, Fujifilm is proud to join the global cancer care community to mark Colorectal Cancer Awareness Month. Did you know that CRC diagnoses are increasingly seen in younger people? A study published by BMJ Journals showed an increase in CRC incidence in adults aged 20–49 years in Europe. The largest increase in CRC incidence occurred among people aged 20–39 years, with incidence of colon cancer increasing by 6.4%-9.3% annually. This is a global trend, and this is why organization's such as the American Cancer Society is recommending lowering the CRC screening age from 50 to 45 years old.

Despite the considerable progress we’ve made in fighting CRC, far too many cases are detected at later stages when treatment options available to people are limited.2 Early screening and diagnosis are the most effective tools in reducing death rates, yet millions still face barriers related to awareness, access, and diagnostic.

Fujifilm is at the forefront of tackling these challenges. Our imaging technologies and state-of-the-art AI-powered diagnostic tools empower clinicians to detect CRC earlier, improve workflow efficiency, and enhance outcomes. Through constant innovation, collaboration, and a commitment to closing and addressing inequity in access, we are driving meaningful change in CRC care, supporting clinicians to deliver the best possible care to their community. 

Elsewhere, across our Life Sciences porfolio, the manufacture of cell culture media and reagents support cutting-edge cancer R&D. 

United against colorectal cancer